Exploring MIA-QSARs' for antimalarial quinolon-4(1H)-imines

Combinatorial Chemistry and High Throughput Screening

Volumn 18, Issue 2, 2015, Pages 208-216

  Duarte, Mariene H ^a   Barigye, Stephen J ^a   Freitas, Matheus P ^a  

^a FEDERAL UNIVERSITY OF LAVRAS   (Brazil)

Author keywords

Malaria; Multiple linear regression; Multivariate image analysis; PLS DA; QSAR; Quinolon 4(1H) imines

Indexed keywords

ANTIMALARIAL AGENT; IMINE; QUINOLON 4(1H) IMINE DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG METABOLISM; DRUG STABILITY; IC50; MODEL; MOLECULAR RECOGNITION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RELIABILITY; CHEMISTRY; DISCRIMINANT ANALYSIS; DRUG EFFECTS; HUMAN; MALARIA; MULTIVARIATE ANALYSIS; PLASMODIUM; REGRESSION ANALYSIS; STATISTICAL MODEL;

ANTIMALARIALS; DISCRIMINANT ANALYSIS; HUMANS; IMINES; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALARIA; MULTIVARIATE ANALYSIS; PLASMODIUM; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUINOLONES;

EID: 84924620957     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/1386207318666141229123349     Document Type: Article

References (29)

1. Hill, D. R.; Ericsson, C. D.; Pearson, R. D.; Keystone, J. S.; Freedman, D. O.; Kozarsky, P. E.; DuPont, H. L.; Bia, F. J.; Fischer, P. R.; Ryan, E. T. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin. Infec. Dis., 2006, 43, 1499-1539.
2. Organisation, W., World Malaria Report 2013. Geneva: WHO 2013.
3. Murray, C. J.; Rosenfeld, L. C.; Lim, S. S.; Andrews, K. G.; Foreman, K. J.; Haring, D.; Fullman, N.; Naghavi, M.; Lozano, R.; Lopez, A. D. Global malaria mortality between 1980 and 2010: A systematic analysis. Lancet, 2012, 379, 413-431.
4. Kappe, S. H.; Kaiser, K.; Matuschewski, K. The Plasmodium sporozoite journey: A rite of passage. Trends Parasit., 2003, 19, 135-143.
5. Lopes, F.; Capela, R.; Gonçaves, J. O.; Horton, P. N.; Hursthouse, M. B.; Iley, J.; Casimiro, C. M.; Bom, J.; Moreira, R. Amidomethylation of amodiaquine: antimalarial N-Mannich base derivatives. Tetrahedron Lett., 2004, 45, 7663-7666.
6. Rodrigues, T.; da Cruz, F. P.; Lafuente-Monasterio, M. J.; Gonçalves, D.; Ressurreição, A. S.; Sitoe, A. R.; Bronze, M. R.; Gut, J.; Schneider, G.; Mota, M. M.; Rosenthal, P. J.; Prudêncio, M.; Gamo, F.-J.; Lopes, F.; Moreira, R. Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria. J. Med. Chem., 2013, 56, 4811-4815.
7. Ressurreição, A. S.; Gonçalves, D.; Sitoe, A. R.; Albuquerque, I. s. S.; Gut, J.; Góis, A.; Gonçalves, L. M.; Bronze, M. R.; Hanscheid, T.; Biagini, G. A. Structural optimization of quinolon-4 (1H)-imines as dual-stage antimalarials: Toward increased potency and metabolic stability. J. Med. Chem., 2013, 56, 7679-7690.
8. Cormanich, R. A.; Goodarzi, M.; Freitas, M. P. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors. Chem. Biol. Drug Des., 2009, 73, 244-252.
9. Freitas, M. P.; Brown, S. D.; Martins, J. A. MIA-QSAR: A simple 2D image-based approach for quantitative structure-activity relationship analysis. J. Mol. Struct., 2005, 738, 149-154.
10. Cormanich, R. A.; Freitas, M. P.; Rittner, R. 2D chemical drawings correlate to bioactivities: MIA-QSAR modelling of antimalarial activities of 2, 5-diaminobenzophenone derivatives. J. Braz. Chem. Soc., 2011, 22, 637-642.
11. Freitas, M. P. MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners. Org. Biomol. Chem., 2006, 4, 1154-1159.
12. Freitas, M. P. Multivariate image analysis applied to QSAR: Evaluation to a series of potential anxiolytic agents. Chemom. Intell. Lab. Sys., 2008, 91, 173-176.
13. Cormanich, R. A.; Nunes, C. A.; Freitas, M. P. Chemical drawings correlate to biological properties: MIA-QSAR. Química Nova, 2012, 35, 1157-1163.
14. Nunes, C. A.; Freitas, M. P. Introducing new dimensions in MIAQSAR: A case for chemokine receptor inhibitors. Eur. J. Med. Chem., 2013, 62, 297-300.
15. Guimarães, M. C.; da Mota, E. G.; Silva, D. G.; Freitas, M. P. aug-MIA-QSPR modelling of the toxicities of anilines and phenols to Vibrio fischeri and Pseudokirchneriella subcapitata. Chemom. Intell. Lab. Sys., 2014, 134, 53-57.
16. Rodrigues, T.; Prudêncio, M.; Moreira, R.; Mota, M. M.; Lopes, F. Targeting the liver stage of malaria parasites: A yet unmet goal. J. Med. Chem., 2011, 55, 995-1012.
17. Godden, J. W.; Stahura, F. L.; Bajorath, J. Variability of molecular descriptors in compound databases revealed by Shannon entropy calculations. J. Chem. Inf. Comp. Sci., 2000, 40, 796-800.
18. Barigye, S. J.; Marrero-Ponce, Y.; Martínez-López, Y.; Torrens, F.; Artiles-Martínez, L. M.; Pino-Urias, R. W.; Martínez-Santiago, O. Relations frequency hypermatrices in mutual, conditional, and joint entropy-based information indices. J. Comput. Chem., 2013, 34, 259-274.
19. Leonard, J. T.; Roy, K. On selection of training and test sets for the development of predictive QSAR models. QSAR Comb. Sci., 2006, 25, 235-251.
20. Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inf., 2010, 29, 476-488.
21. Golbraikh, A.; Tropsha, A. Beware of q2. J. Mol. Graph. Model., 2002, 20, 269-276.
22. Mitra, I.; Saha, A.; Roy, K. Exploring quantitative structure-activity relationship studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants. Mol. Simul., 2010, 36, 1067-1079.
23. Ojha, P. K.; Mitra, I.; Das, R. N.; Roy, K. Further exploring rm2 metrics for validation of QSPR models. Chemom. Intell. Lab. Sys., 2011, 107, 194-205.
24. Roy, K.; Mitra, I.; Kar, S.; Ojha, P. K.; Das, R. N.; Kabir, H. Comparative studies on some metrics for external validation of QSPR models. J. Chem. Inf. Model., 2012, 52, 396-408.
25. Medić-Šarić, M.; Rendić, S.; Puljko, D.; Š arić, S. Molecular Modelling and Lipophilicity in Research of Drugs and Chemicals. London, 1996.
26. Moriguch, I.; Kanada, Y.; Komatsu, K. Van der Waals volume and the related parameters for hydrophobicity in structure-activity studies. Chem. Pharm. Bull., 1976, 24, 1799-1806.
27. Cowley, R.; Leung, S.; Fisher, N.; Al-Helal, M.; Berry, N. G.; Lawrenson, A. S.; Sharma, R.; Shone, A. E.; Ward, S. A.; Biagini, G. A. The development of quinolone esters as novel antimalarial agents targeting the Plasmodium falciparum bc 1 protein complex. MedChemComm, 2012, 3, 39-44.
28. Wold, S.; Sjöström, M.; Eriksson, L. PLS-regression: A basic tool of chemometrics. Chemom. Intell. Lab. Sys., 2001, 58, 109-130.
29. Zhang, Y.; Clark, J. A.; Connelly, M. C.; Zhu, F.; Min, J.; Guiguemde, W. A.; Pradhan, A.; Iyer, L.; Furimsky, A.; Gow, J. Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials. J. Med. Chem., 2012, 55, 4205-4219.